Mesoblast is headquartered in Melbourne, Australia.
Mesoblast disclosed revenue of 17M USD for 2025 and 6M USD for 2024.
Mesoblast has 81 employees.
Mesoblast is a life science company.
Mesoblast was founded in 2004.
55 Collins Street, Level 38,
Melbourne,
VIC 3000
Australia,
+61 3 9639 6036
www.mesoblast.com
Mesoblast is a biotherapeutics company with proprietary cell-based and protein technologies. Mesoblast’s technology platforms have the potential to deliver a diverse portfolio of clinical-stage products to treat major conditions with unmet medical needs. Mesoblast was founded in 2004 and is based in Melbourne, Australia.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 2 | - | - | - | - | - | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
